MacroGenics director receives 44,000 stock options

The option vests in monthly 1/36th increments, while 33% of the RSUs vest one year after grant and 33% each year thereafter.

Available on EDGAR 11/03/2026 - 04:33 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

MacroGenics Inc. director Emil Kuriakose received a stock option covering 44,000 common shares, with a $2.40 exercise price, and 7,500 restricted stock units on October 30, 2026. The option vests in monthly, cumulative 1/36th increments beginning one month after grant and expires October 30, 2036. Each RSU represents a contingent right to one common share; 33% vest one year after grant and 33% each year thereafter.

Insider Trade Summary

Grant/Award: 51,500 shares

Grant/Award 2 txns

Insider Kuriakose Emil

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	44,000	$0.00	$0.00
Grant/Award	Restricted Stock Unit F2	7,500	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 44,000 contracts (Direct); Restricted Stock Unit — 7,500 contracts (Direct)

Footnotes (2)

1. F1. The option will vest and become exercisable in monthly, cumulative 1/36th increments (rounded upwards for whole shares) beginning one month from the date of grant.
2. F2. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Key Figures

Common shares underlying stock option: 44,000 shares Restricted stock units: 7,500 units Exercise price: $2.40 per share +3 more

6 metrics

Common shares underlying stock option 44,000 shares Option granted October 30, 2026

Restricted stock units 7,500 units Granted October 30, 2026

Exercise price $2.40 per share Stock option granted October 30, 2026

Option vesting 1/36th increments Monthly, cumulative increments beginning one month from the date of grant; rounded upwards for whole shares

Option expiration October 30, 2036 Stock option expiration date

RSU vesting 33% 33% of total shares vest one year after grant and 33% each year thereafter

Key Terms

Stock Option (right to buy), Restricted Stock Unit, contingent right, exercisable

4 terms

Stock Option (right to buy) financial

"Stock Option (right to buy)"

Restricted Stock Unit financial

"Each restricted stock unit (RSU) represents"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right technical

"a contingent right to receive one share"

exercisable financial

"will vest and become exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MGNX options and restricted stock units did Emil Kuriakose receive?

Emil Kuriakose received an option covering 44,000 common shares and 7,500 restricted stock units on October 30, 2026; the option's exercise price is $2.40 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kuriakose Emil

(Last) (First) (Middle)

9704 MEDICAL CENTER DRIVE

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MACROGENICS INC [ MGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.4	10/30/2026		A		44,000		(1)	10/30/2036	Common Stock	44,000	$0	44,000	D
Restricted Stock Unit	(2)	10/30/2026		A		7,500		(2)	(2)	Common Stock	7,500	$0	7,500	D

Explanation of Responses:

1. The option will vest and become exercisable in monthly, cumulative 1/36th increments (rounded upwards for whole shares) beginning one month from the date of grant.

2. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Remarks:

	/s/ Beth A. Smith, Attorney-in-fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)